OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Immunogenicity, clinical efficacy and safety of additional second COVID‐19 booster vaccines against Omicron and its subvariants: A systematic review
Santenna Chenchula, Madhu Bhargavi Chandra, Madhu Babu Adusumilli, et al.
Reviews in Medical Virology (2024) Vol. 34, Iss. 1
Closed Access | Times Cited: 5
Santenna Chenchula, Madhu Bhargavi Chandra, Madhu Babu Adusumilli, et al.
Reviews in Medical Virology (2024) Vol. 34, Iss. 1
Closed Access | Times Cited: 5
Showing 5 citing articles:
Antigen-specific T helper cells and cytokine profiles predict intensity and longevity of cellular and humoral responses to SARS-CoV-2 booster vaccination
Lukas Page, Kevin M. Dennehy, Katharina Mueller, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 2
Lukas Page, Kevin M. Dennehy, Katharina Mueller, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 2
Current German Recommendations and International Research on the Use of COVID-19 Boosters among Health Care Providers in 2024: A Narrative Review
Poramate Pitak‐Arnnop, Popchai Ngamskulrungroj, Nithi Mahanonda, et al.
Medicina (2024) Vol. 60, Iss. 3, pp. 385-385
Open Access | Times Cited: 1
Poramate Pitak‐Arnnop, Popchai Ngamskulrungroj, Nithi Mahanonda, et al.
Medicina (2024) Vol. 60, Iss. 3, pp. 385-385
Open Access | Times Cited: 1
Global domination of the recently VoI-classified 'JN.1′ outcompeting other variants – Comparing the vaccines’ efficacy
Ranjan K. Mohapatra, Venkataramana Kandi, Abhay Gaidhane, et al.
Clinical Infection in Practice (2024) Vol. 22, pp. 100358-100358
Open Access | Times Cited: 1
Ranjan K. Mohapatra, Venkataramana Kandi, Abhay Gaidhane, et al.
Clinical Infection in Practice (2024) Vol. 22, pp. 100358-100358
Open Access | Times Cited: 1
In vitro antibody-mediated SARS-CoV-2 infection suppression through human ACE2 receptor blockade
Priscilla S. Redd, Alyssa D. Merting, John D. Klement, et al.
Immunology Letters (2024) Vol. 268, pp. 106887-106887
Closed Access
Priscilla S. Redd, Alyssa D. Merting, John D. Klement, et al.
Immunology Letters (2024) Vol. 268, pp. 106887-106887
Closed Access
T Cell Responses to BA.2.86 and JN.1 SARS-CoV-2 Variants in Elderly Subjects
Irene Segato, Dalila Mele, Greta Forlani, et al.
Vaccines (2024) Vol. 12, Iss. 12, pp. 1451-1451
Open Access
Irene Segato, Dalila Mele, Greta Forlani, et al.
Vaccines (2024) Vol. 12, Iss. 12, pp. 1451-1451
Open Access
